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Abstract 
Introduction: Bone marrow is the site of involvement of various neoplasms. The objective of this study was to 
determine the incidence of various malignancies (Haematological and non-Haematological) in adults diagnosed 
on morphological examination of bone marrow. 
Materials and Methods: It was a single-centre, retrospective study conducted at the Department of Pathology, 
Fauji Foundation Hospital, Rawalpindi from January 2012 to December 2018. All patients above 15 years of age 
diagnosed as having Haematological or Non-Haematological malignancy involving bone marrow were included 
in the study. Data was analyzed using SPSS version 17. 
Results: A total of 275 adult patients had malignancies involving bone marrow; 233 (84.7%) were females and 42 
(15.3%) were males.  Out of 275 patients, 50 (18.1%) patients had Acute Myeloid Leukaemia, 45 (16.3 %) had 
Chronic Myeloid Leukaemia (CML), 41 (14.9 %) having Non-Hodgkin lymphoma (NHL), 32 (11.6 %) having 
Acute Lymphoblastic Leukaemia (ALL), 31 (11.2 %) having Chronic Lymphocytic Leukaemia (CLL) and 27 (9.8 
%) having Plasma cell Myeloma. Metastatic infiltrates were seen in 16 (5.8 %) patients. Myeloproliferative 
neoplasms (MPN) in 6 (2.1%), Essential Thrombocythaemia in 5 (1.8 %), Polycythaemia vera in 4 (1.4%), Primary 
myelofibrosis in 2 (0.7 %), Hodgkins Lymphoma in 2 (0.7 %), and Plasma Cell Leukaemia in 1 (0.3 %) patient were 
seen. Thirteen (4.7%) patients of Acute leukaemia and 6 (2.1%) patients of MPN required further testing by 
Immunophenotyping/Cytogenetics for a conclusive diagnosis. 
Conclusion: Leukaemias were the most common malignancies involving bone marrow, followed by Non-
Hodgkin Lymphomas, Plasma cell myeloma and Metastatic infiltrates. Morphology by light microscopy remains 
the single most useful tool for the diagnosis of malignancies, especially in under-resourced centres. 
Keywords: Leukaemias, Lymphomas, Metastasis, Plasma cell myeloma. 
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Introduction 
 
The incidence of malignancies is increasing 
worldwide. It affects people of both genders and all 
age groups.1 Many of these involve the bone marrow. 
Leukaemias (acute and chronic) originate primarily 
within the bone marrow. These may be myeloid or 
lymphoid.2 Others are lymphomas that arise due to 
clonal lymphoid proliferations. These are classified as 
Hodgkins Lymphoma (HL) and Non-Hodgkins 
Lymphomas (NHL). Lymphomas are primarily 
diagnosed on tissue biopsies. Bone marrow aspiration 
and trephine biopsy to detect bone marrow infiltration 
are carried out as part of the staging procedure.3 A 
small percentage of Hodgkin's lymphoma patients 
have bone marrow involvement (Sudalaimuthu 
M1, Basu D).4 NHL may be low grade or high grade. 
Low-grade lymphomas are more likely to involve bone 
marrow of the patient (Brudno et al 2016).5 
Bone marrow may also be involved by several Non-
Haemopoietic tumours, commonest being originating 
from the prostate, breast, lung, thyroid, kidney, and 
stomach. Bone marrow involvement by solid tumours 
has an impact on overall survival and treatment 
response of the patient. (Kucukzeybek BB et al 2014).6 
In the case of leukaemias, bone marrow aspirate is 
usually sufficient to make the diagnosis. However, 
bone marrow trephine biopsy is required in cases 
where bone marrow aspirate alone is not sufficient to 
provide adequate information, for example in cases 
with fibrosis (Gandapur et al., 2015)7 or a dry tap 
(trephine imprints may be helpful), a pattern of 
involvement in lymphomas and metastatic deposits 
(Mangoch A).8 
With the introduction of new techniques for diagnosis 
eg immunophenotyping, immunohistochemistry, and 
cytogenetics, the diagnosis of malignancies has 
become more accurate. However, morphological 
examination remains the first-line tool for diagnosis of 
disorders of bone marrow examination. In our 
country, these techniques are not available in most of 
the laboratories.  
The present study was undertaken to assess the role of 
morphological examination to detect the incidence of 
various haematological and non-haematological 
malignancies involving bone marrow in adults.             
                                                 
Material & Methods 
 
It was a retrospective study and data was taken from 
1st January 2012 to 31st December 2018 at the 
Department of Pathology, Fauji Foundation Hospital, 
Rawalpindi. Results of bone marrow examination of 
patients above 15 years of age were analyzed. Cases of 
relapse of malignancies and follow up cases of 
Haematological and Non-Haematological 
malignancies were excluded from the study, to avoid 
duplication. In all cases, a thorough history and 
clinical examination were performed. Complete blood 
counts were obtained using automated haematology 
analyzer Sysmex XT-2000i and Xn-1000.   Bone 
marrow aspiration and trephine biopsy were taken 
from the posterior superior iliac spine. Peripheral 
blood smear and bone marrow aspirate were stained 
using Leishman stain. Cytochemistry i.e. Sudan Black 
B (SBB), Acid Phosphatase (ACP), Periodic Acid Schiff 
(PAS), Alpha naphthyl acetate esterase (ANAE), and 
Leukocyte alkaline phosphatase (LAP) were applied to 
bone marrow aspirate for typing of leukaemias. 
Trephine biopsy was processed using a standard 
protocol. A silver impregnation technique was done 
for reticulin staining to assess fibrosis. 
Immunophenotyping and Cytogenetics of the patients 
were sent in selected cases with an inconclusive 
diagnosis on morphology. Data was entered in and 
analyzed by using Statistical Package for the Social 
Sciences (SPSS) version 17. Mean and median were 
used to express quantitative variables, whereas 
qualitative variables were expressed using frequency 
and percentages. 
 
Results 
 
A total of 2242 bone marrows were performed. Out of 
these, 275 were the adults having bone marrow 
malignancies. 
A total of 275 adult patients had malignancies 
involving bone marrow; 233 (84.7%) were females and 
42 (15.3%) were males.  Out of 275 patients, 50 (18.1%) 
had Acute Myeloid Leukaemia, 45 (16.3 %) had 
Chronic Myeloid Leukaemia (CML), 41 (14.9 %) 
having Non-Hodgkin lymphoma (NHL), 32 (11.6 %) 
having Acute Lymphoblastic Leukaemia (ALL), 31 
(11.2 %) having Chronic Lymphocytic Leukaemia 
(CLL) and 27 (9.8 %) having Plasma cell Myeloma. 
Metastatic infiltrates were seen in 16 (5.8 %) patients. 
Myeloproliferative neoplasms (MPN) in 6 (2.1%), 
Essential Thrombocythaemia in 5 (1.8 %), 
Polycythaemia vera in 4 (1.4%), Primary myelofibrosis 
in 2 (0.7 %), Hodgkins Lymphoma in 2 (0.7 %), and 
Plasma Cell Leukaemia in 1 (0.3 %) patient were seen. 
Thirteen (4.7%) patients of Acute leukaemia and 6 
125                                                                             Journal of Rawalpindi Medical College (JRMC); 2020; 24(2): 123-127 
(2.1%) patients of MPN were diagnosed by 
Immunophenotyping/Cytogenetics. 
Prevalence and age-distribution of various 
malignancies and frequencies of males and females are 
shown in Table 1 and Figure 1 respectively. 
Table 1: Basic Clinical Features 
Disorder n Percentage 
(%) 
Median 
age (years) 
AML 50 18.1 51 
CML 45 16.3 48 
NHL 41 14.9 57 
ALL 32 11.6 48 
CLL 31 11.2 67 
PCM 27 9.8 62 
Metastasis 16 5.8 50.5 
Acute Leukemia  13 4.7 50 
MPN 6 2.1 62 
ET 5 1.8 38 
PV 4 1.4 47.5 
PMF 2 0.7 61.5 
HL 2 0.7 64.5 
PCL 1 0.3 38 
Total  275   
 
 
 
Figure 1: Frequencies of Males and Females  
 
Discussion 
  
Bone marrow examination is crucial for the diagnosis 
of various hametological malignancies as well as for 
the staging of Lymphomas and Non Haematological 
tumours. 
 
The diagnosis involves a multi-step procedure. In the 
case of leukaemias, the FAB classification based on the 
morphological examination of peripheral blood smear 
and bone marrow aspirate along with cytochemistry is 
sufficient for diagnosis. Newer techniques including 
immunophenotyping help classify the subtypes of 
AML and ALL as well as establishing the diagnosis in 
cases with ambiguous morphology, whereas 
cytogenetics and molecular analysis are predictors of 
prognosis and minimal residual disease, respectively. 
Regarding lymphomas, these tests are also helpful in 
confirmation of the diagnosis in case of bone marrow 
aspirate/biopsy showing involvement by lymphoid 
infiltrate. Immunohistochemistry on bone marrow 
trephine biopsy specimen is used to diagnose cases 
showing metastasis in bone marrow with an unknown 
primary site. However, these techniques are not 
available in a large majority of setups in our country. 
A prompt diagnosis is required to start the 
management which is readily provided by 
morphological examination of peripheral blood smear 
and bone marrow of the patient.   
In our study, Leukaemias was the most common 
disorder followed by Lymphoma, Plasma cell 
myeloma and Metastasis. Among leukaemias, acute 
leukemias were more common compared to chronic 
leukaemias. A study conducted by Gandapur et al,7 
Khan M I9, and Kusum et al10 found a similar 
distribution of malignancies in the bone marrow.  
Among Acute leukaemias in our study, Acute myeloid 
leukaemia was more prevalent than Acute 
Lymphoblastic Leukaemia. The former studies (by 
Gandapur et al and Khan MI) have shown more cases 
of ALL compared to AML. This is most likely because 
of the reason that peadiatric patients were also 
included in that study along with adult patients and 
ALL is more common in children. A study by Kusum 
et al have shown comparable results to our study. The 
majority of the patients in that study are adults 
(n=103) compared to children (n=26). A study by 
Hossain et al11 have also shown more cases of AML 
compared to ALL; among those diagnosed as ALL in 
those studies, the majority were children.  
The bone marrow of 43 (15.6%) patients was involved 
by Lymphomas. There were 41 (14.9%) cases of Non-
Hodgkins lymphomas (NHLs) and only 2 (0.7%) cases of 
Hodgkins Lymphoma. This is because of the lower 
incidence of involvement of bone marrow by HL as 
compared to NHLs (Sudalaimuthu M, Basu D., 2016).12 
There were patients of all age groups with a median 
age of 57 years and 64.5 years for NHL and HL 
respectively. A study by Sultan S et al showed a 
slightly lower age distribution of 50 years for NHL.13 
In England the median age was much higher i.e 69.1 
years (Smith et al., 2015).14 The difference in age is 
based on the ethnic distribution with people in Europe 
developing the disease at older ages, most likely due 
to a longer life expectancy in West (Sultan S et al 
2018).13 A much lower median age i.e 30 years was 
reported for Hodgkin's lymphoma in a study 
126                                                                             Journal of Rawalpindi Medical College (JRMC); 2020; 24(2): 123-127 
previously conducted in Pakistan (Sultan et al 
2016).15That study was exclusively performed on 
patients of Hodgkin's lymphoma and with large 
sample size. Data from West, however, suggests first 
peak incidence in younger individuals as well as the 
second one in more than 60 years of age (W Townsend 
2012).16 
Plasma cell myeloma (PCM) constituted 27 cases 
(9.4%) of all malignancies. This is following a study 
previously conducted by Khan H 17 which showed 
10.2% of patients involved by multiple myeloma. It 
also corresponds to the global data according to which 
the prevalence of PCM is approximately 10% of all 
Haematological malignancies (Hameed A et al).18 
Median age of the patients was 62 years. A slightly 
lower median age of 57 years has been reported for 
PCM patients in a study conducted by Sultan S et al 
2016.19 This study was carried out with larger sample 
size. Also, the difference in the stage of presentation of 
patients to health care facility might be a contributory 
factor. A higher median age of 70 years has been 
reported in West (Hameed A et al).19 A longer life 
expectancy and better health care facilities of people in 
the West compared to those in our country is probably 
the reason for the difference reported. 
There was one case of Plasma cell leukaemia (PCL) 
which corresponds with its rare occurrence worldwide 
(Ravi et al 2018).20 
Among Chronic leukemias, the incidence of Chronic 
Myeloid Leukemia (CML) was higher as compared to 
Chronic Lymphocytic leukemia (CLL), 45 patients 
(16.3 %) vs 31 patients (11.3 %). This is following 
studies previously done in Pakistan which showed 
that 12.4% of patients had CML and 9.8% had CLL. 
(Gandapur et al).7 In Europe, however patients with 
CLL constitute a higher percentage compared to those 
with CML. (Sant M et al., 2010).21 This is due to the 
geographical differences in the distribution of CLL 
which is more common in Western than Asian 
countries (Schwartz GG, Klug MG.).22 
Certain disorders were infrequently reported in our 
study including Myeloproliferative neoplasms comprising 
of 5 (1.8 %) Essential Thrombocythaemia (ET), 4 (1.4 
%) Polycythaemia Vera (PV) and 2 (0.7 %) Primary 
myelofibrosis (PMF). The data reported by Yap et al 23 
have reported the same prevalence whereas a study 
previously conducted in Pakistan showed PV as the 
most prevalent MPN (Sheikh et al 2016).24 However, 
the data from our study is scarce and may not be a 
representative of the prevalence of these disorders. 
The involvement of bone marrow in a patient by non-
Haematologic tumour is indicative of the advanced 
stage of that tumour and a poor prognosis. There were 
16 (5.6 %) cases of Metastatic infiltrates involving bone 
marrow.  A lower number of patients had metastatic 
deposits on bone marrow examination in a study 
previously conducted in Pakistan25 i.e 10/443 patients 
(2.2%) while another study conducted by Mangoch A 8 
showed a very low frequency 6/1600 patients (0.3%). 
The difference in prevalence is likely due to the timely 
presentation and ease of access to a health care facility. 
The above data indicate that the prevalence of various 
malignant disorders fairly correlates with that 
provided in other setups. Only a small proportion of 
our patients 6.8% required further testing to achieve a 
diagnosis. This shows that morphology alone can 
provide sufficient evidence for the diagnosis of 
malignancies. 
 
Limitations 
  
A female predominance was observed in our study in 
all types of malignancies. This is because our hospital 
mainly caters for female and children. Therefore our 
data is not representative of gender distribution in 
various types of malignancies.  A study with a larger 
sample size including males is needed in this regard.  
 
Conclusion 
  
Acute and chronic leukaemias form the most common 
malignancies diagnosed with bone marrow 
examination in our study. A significant proportion of 
patients had bone marrow involvement by lymphomas 
whereas metastasis by solid tumours was relatively 
low. Only a small percentage of patients required 
further testing to reach a conclusive diagnosis. 
Therefore morphology by light microscopy remains 
the single most useful tool for diagnosis of 
malignancies, especially in under-resourced centres.  
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